StITCH 1.0
Strengthening Integrated Treatment and Care for Hepatitis in Vietnam and the Philippines
Bringing hepatitis care closer to where people live.
StITCH 1.0 worked with local governments and frontline health workers to integrate hepatitis B and C services into public primary care. Its people-centered model connects screening, assessment, treatment, and continuing care, with specialist support for patients who need it.
In the Philippines, the model was developed and implemented in Tarlac Province and Quezon City. The project combined service delivery, workforce development, research, and continuous improvement to help local health systems respond to the needs of people living with hepatitis. The original project phase ended on 30 September 2026; its implementation experience and resources provide a foundation for sustaining services and adapting the model to other settings.
Part of StITCH. This page documents the completed first phase. StITCH 2.0 builds on this experience through current preparation and joint planning in Dasmariñas City. Completion of the funded first phase does not mean that local hepatitis services have ended.
Results · Model of care · Research · Highlights

Hepatitis care in a StITCH partner facility. Photo: Tarlac Provincial Health Office.
Results at a glance
31,000+
People screened for hepatitis B in the Philippines
72%
People who tested positive returned for follow-up care
95%
Eligible patients initiated treatment immediately
Philippine results reported in Manila Bulletin, 23 September 2026. The percentages describe different stages of care and have different denominators.
The one-stop primary care approach also shortened the reported time to linkage to care from more than four months to less than one week, streamlining the journey from screening to consultation.
The experience shows how trained primary care teams, supported by clear care pathways and specialist mentoring, can deliver hepatitis services closer to communities. Sustaining progress also requires reliable access to diagnostic tests, medicines, and follow-up.
Why StITCH?
Hepatitis can remain undetected until serious liver disease develops. Access to testing and treatment is uneven, and a referral to specialist care can mean additional travel, expense, and delays for patients.
StITCH responds by bringing services into facilities where people already seek care. Its design draws on a strategic landscape analysis in Viet Nam and the Philippines, alongside patient journey mapping and facility assessments. Together, this work helps identify gaps between available services and people’s actual experience of getting care.
Our model of care
The StITCH model is people-centered and LGU-led. It brings together accessible entry points, counseling, supported navigation, treatment for uncomplicated cases, and continuing monitoring. Primary care facilities work within a referral network so that patients can receive specialist assessment when needed.
Four ways we make primary care delivery work
More entry points
Integrate hepatitis screening into routine services, such as noncommunicable disease clinics, TB and HIV services, and community activities, to reach people who might otherwise remain untested.
Task-sharing
Equip primary care doctors, nurses, and other frontline staff with practical training, clear algorithms, and defined roles across the care pathway.
Telementoring
Connect frontline teams with specialist mentors through case-based virtual discussions that support clinical decisions and continuing learning.
Continuous improvement
Use routine data and feedback from patients and providers to identify bottlenecks, test practical changes, and improve services over time.
A connected facility network
- Screening, Assessment and Treatment Facilities (SATFs): frontline facilities providing screening, assessment, counseling, treatment for uncomplicated cases, and monitoring, according to local capacity and agreed pathways.
- End-Referral Facilities (ERFs): referral hospitals providing specialist assessment and management for complicated cases, with diagnostic services coordinated across the network.
The network is adapted to each local setting, including the facilities, workforce, laboratory services, and referral arrangements available.
What we learned
Delivering hepatitis care requires attention to the whole patient journey. Screening must lead to assessment; eligible patients must be able to start treatment; and patients need support to stay connected to care.
Implementation has highlighted priorities for local health systems:
- Make the next step clear. Counseling, case management, and referral coordination help patients navigate care after a reactive screening result.
- Support frontline teams. Training and mentoring need to accompany changes in clinical roles and responsibilities.
- Keep tests and medicines available. Diagnostic access, specimen transport, and procurement affect progress through the care pathway.
- Use data to improve care. Reviewing the cascade helps teams identify where patients encounter delays and where services need to change.
- Address stigma and build trust. Respectful counseling, accurate information, and engagement with people living with hepatitis help reduce barriers to testing and continuing care.
Tools for implementation and learning
StITCH’s implementation and learning resources include:
- Model of care and implementation package: practical guidance for adapting service delivery to a local health system.
- Hepatitis B computer-based training: structured learning to support frontline provider competency.
- Case-based telementoring: continuing support for primary care teams managing hepatitis.
- Patient journey mapping and facility assessment: approaches for understanding people’s needs and local service readiness.
Research and publications
StITCH brings implementation experience together with research on access, patient experience, and health-system readiness.
Further analyses are being developed on the care cascade, patient experience, workforce development, quality improvement, and the resources needed to sustain delivery.
Journal article
Healthcare system readiness to manage viral hepatitis in Viet Nam and the Philippines
Martin Louis Fernandez, Hoang Nguyen, Dang Nguyen, et al.
BMC Health Services Research · 2026
Authors and abstract
Authors: Martin Louis Fernandez, Hoang Nguyen, Dang Nguyen, Bethany Holt, Duong Doan, Manu Gaspar, Geohari Hamoy, Jhaki Mendoza, Timothy Bill Mercado, Daniel Joy Cabauatan, Huyen Nguyen, My Dang, Vy Nguyen, Janus Ong, Joseph Michael Manlutac, Yen Nguyen, Hoa Nguyen, Dung Vu, Jan Philip Florendo, Danica Delima, Mary Cris Rombaoa, Jose Mateo Dela Cruz, Rosanna Buccahan, Hjordis Marushka Celis, Jeanette Lazatin, Pham Nam Thai, Pham Xuan Truong, Tran Khanh Thu, Thuy Pham, David Duong, Todd Pollack
A mixed-methods health facility assessment evaluating the readiness of primary healthcare systems in Viet Nam and the Philippines to deliver hepatitis B and C services, identifying critical gaps in diagnostics, workforce capacity, treatment access, and health financing.
Journal article
Putting people at the center: methods for patient journey mapping of viral hepatitis services across two LMICs in the Asia Pacific
Bethany Holt, Jhaki Mendoza, Hoang Nguyen, et al.
BMC Health Serv. Res. · 2025
Authors and abstract
Authors: Bethany Holt, Jhaki Mendoza, Hoang Nguyen, Duong Doan, Thu Huyen Nguyen, Timothy Bill Mercado, Lam Dam Duy, Martin Fernandez, Manu Gaspar, Geohari Hamoy, Bao Ngoc Le, Boon-Leong Neo, Vy Nguyen, Thuy Pham, Janus Ong, Todd M Pollack, Jae-Ann Sumalo, Pham Thai, David B Duong
BACKGROUND: To ensure that health services are high-quality, trusted and used by the population, their design and improvement should start from the perspective of what matters to people. Patient journey mapping (PJM) is one research method that centers the experiences of individuals living with health conditions and follows their pathways through care and recovery. This paper describes a novel, qualitative PJM methodology used in Vietnam and the Philippines to inform the co-design of a people-centered viral hepatitis screening, care and treatment pathway for individuals living with chronic hepatitis, which is a significant public health concern in the Asia-Pacific region. METHODS: Data collection involved in-depth interviews with a purposive sample of 63 people living with hepatitis (demand-side) and focus group discussions with healthcare providers working in the same geographical areas (supply-side). Rapid deductive qualitative analysis was used to identify typical journeys, and related barriers and enablers. The methodology was implemented over 8 weeks, adapting the Consolidated Criteria for Reporting Qualitative Research (COREQ). RESULTS: This paper demonstrates how a PJM methodology that incorporates patient and HCP perspectives can be feasibly implemented in two LMIC contexts, while fulfilling many of the criteria identified by the COREQ guidelines. Sharing such methods and associated instruments may help to enable broader uptake and application in other LMIC settings, providing health systems practitioners with a critical tool to identify and overcome barriers in and promote the delivery of people-centered health services globally. CONCLUSION: Despite limited uptake, especially in resource-limited contexts and at the primary healthcare level, PJM is a novel research method with the potential to make promising contributions to people-centered health service design.
Journal article
Stigma among primary care providers: characterizing attitudes and behaviors in the care of people with chronic hepatitis in the Philippines
Naeema Hopkins-Kotb, Jhaki Mendoza, Manu Gaspar, et al.
BMC Prim. Care · 2025
Authors and abstract
Authors: Naeema Hopkins-Kotb, Jhaki Mendoza, Manu Gaspar, Martin Fernandez, Jae-Ann Sumalo, Timothy Mercado, Jovein Alcantara, Joshua Bartolome, Diana Rose de Silva, Janus P Ong, Todd M Pollack, David B Duong, Bethany Holt
BACKGROUND: Stigma is a key barrier to compassionate primary health care delivery and people-centered care (PCC), but is understudied among primary care providers (PCPs). Hepatitis B and C have a significant burden of disease in the Philippines, where there is limited awareness of and access to screening and treatment. Patient-reported stigma has been identified as a significant barrier to hepatitis care in the Philippines, but PCP stigma-related attitudes and behaviors have not been explored in this context. METHODS: In this study, we assessed primary PCP-reported stigma-related attitudes and behaviors toward patients with hepatitis B and C. We surveyed primary PCPs in Tarlac, Philippines working within a network of healthcare facilities that have been part of an initiative to decentralize hepatitis care to the primary care level and prioritize PCC. RESULTS: We found that PCPs' self-reported attitudes toward patients with hepatitis B and C reflect a strong sense of responsibility to provide care, and comfort with sensitive history-taking, but also pervasive attitudes of pity and blame. PCPs' self-reported behaviors showed commitment to providing equal care, but variation in infection control practices suggesting misconceptions about transmission risk. CONCLUSIONS: Our results provide essential insight into PCPs' stigma-related attitudes and behaviors that will serve as a baseline for future comparison with patient-reported experiences. These findings underscore the critical role of primary care in addressing stigma and improving hepatitis care in the Philippines, highlighting the importance of training, resource allocation, and people-centered care strategies.
Sustaining and expanding the work
Following the end of the original phase on 30 September 2026, the priority is to help local health systems sustain hepatitis services and adapt the model to additional settings. Priorities include embedding provider training into continuing education, maintaining specialist mentoring, strengthening community participation, and improving financing for tests, medicines, and follow-up.
These are areas of continuing work with government, clinical, academic, and community partners. Institutional adoption and wider implementation will depend on agreed responsibilities, resources, and local readiness.
StITCH 2.0 is a distinct, US CDC-funded phase, with current preparation and joint planning in Dasmariñas City as part of the proposed STEP-StITCH initiative. Its funding, scope, and updates are presented separately from the completed first phase.
Project highlights
Featured media and news
30 Sep 2026
StITCH completes its original project phase
The original StITCH phase concluded on 30 September. We thank our partners in Tarlac and Quezon City and all who contributed to bringing hepatitis care closer to communities.
Read more →
Featured activity
UPM Liver Study Group shares StITCH 1.0 lessons with DOH hepatitis trainers
The UPM Liver Study Group contributed sessions on the StITCH 1.0 model of care, hepatitis B computer-based training, and telementoring to the DOH Training of Trainers.
Read more →Partners
StITCH 1.0 was supported by Gilead Sciences through Harvard Medical School. Implementing institutions included the University of the Philippines Manila, Harvard Medical School, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Partnership for Health Advancement in Viet Nam.
In the Philippines, implementation was undertaken with local government and health-facility teams in Tarlac and Quezon City. Specialist mentoring involved the Hepatology Society of the Philippines, with community engagement involving the Yellow Warriors Society of the Philippines.
To explore collaboration, implementation resources, or research, visit Janus Ong, MD, MPH’s profile or the UPM Liver Study Group’s Join Us page.
Page revised: 26 October 2026.
This project was carried out in collaboration with and the support of Gilead Sciences, and was implemented by the University of the Philippines Manila, Harvard Medical School, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Partnership for Health Advancement in Viet Nam.